RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 83 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $320,000 | 0.0% | 114,953 | +2.1% | 0.00% | – |
| Q4 2020 | $320,000 | +39.1% | 112,536 | +2.8% | 0.00% | – |
| Q3 2020 | $230,000 | -62.7% | 109,474 | -19.3% | 0.00% | – |
| Q2 2020 | $617,000 | -79.3% | 135,574 | -62.8% | 0.00% | -100.0% |
| Q1 2020 | $2,979,000 | -45.2% | 364,622 | +22.9% | 0.00% | -50.0% |
| Q4 2019 | $5,438,000 | +91.7% | 296,658 | +15.9% | 0.00% | +100.0% |
| Q3 2019 | $2,836,000 | -17.9% | 255,984 | -24.6% | 0.00% | 0.0% |
| Q2 2019 | $3,455,000 | – | 339,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|